On 8 January 2014, Canada reported a fatal imported case of influenza A(H5N1) infection. This is the first confirmed human case of H5N1 in North America.
Without baseline human immunity to the emergent avian influenza A(H7N9) virus, neuraminidase inhibitors are vital for controlling viral replication in severe infections.
In response to the correspondence published in The Lancet, “Polio emergence in Syria and Israel endangers Europe”, ECDC replied clarifying the Centre’s recommendations to Member States.
Ten of the 22 acute flaccid paralysis (AFP) cases in the Syrian Arab Republic suspected of being caused by wild poliovirus have been confirmed as wild poliovirus type 1 (WPV1) by the World Health Organization (WHO).
On 14 August 2013 highly pathogenic avian influenza (HPAI) was detected in poultry in Ostellato, Ferrara province, Emilia-Romagna, Italy. Influenza subtype A(H7N7) was confirmed.
On 14 August 2013 highly pathogenic avian influenza (HPAI) was detected in poultry in Ostellato, Ferrara province, Emilia-Romagna, Italy. Influenza subtype A(H7N7) was confirmed.
Since 31 March 2013, one hundred and twenty one (121) cases of human infection with avian influenza A(H7N9) virus have been reported from eight provinces and two municipalities in eastern China and one (1) from Taiwan.